These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23051725)

  • 1. Topical therapies in inflammatory bowel disease.
    Frei P; Biedermann L; Manser CN; Wilk M; Manz M; Vavricka SR; Rogler G
    Digestion; 2012; 86 Suppl 1():36-44. PubMed ID: 23051725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
    Richter JM; Kushkuley S; Barrett JA; Oster G
    Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical therapy is underused in patients with ulcerative colitis.
    Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
    J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
    Jo Y; Matsumoto T; Iida M
    Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 6. Budesonide for the treatment of ulcerative colitis.
    Abdalla MI; Herfarth H
    Expert Opin Pharmacother; 2016 Aug; 17(11):1549-59. PubMed ID: 27157244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of ulcerative colitis].
    Rammert Ch; Kullak-Ublick GA
    Ther Umsch; 2003 Mar; 60(3):145-50. PubMed ID: 12693317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patients prefer foam].
    MMW Fortschr Med; 2007 May; 149(21):48. PubMed ID: 17668735
    [No Abstract]   [Full Text] [Related]  

  • 10. Ulcerative proctitis: a review of pharmacotherapy and management.
    Lakatos PL; Lakatos L
    Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.
    Harris MS; Lichtenstein GR
    Aliment Pharmacol Ther; 2011 May; 33(9):996-1009. PubMed ID: 21385194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines of the DGVS. Acute process. German Society of Digestive and Metabolic Diseases].
    Fleig WE;
    Z Gastroenterol; 2001 Jan; 39(1):33-8. PubMed ID: 11215362
    [No Abstract]   [Full Text] [Related]  

  • 13. [Topical therapy of ulcerative colitis].
    Rogler G; Beglinger C; Mottet C; Seibold F; Gross V
    Praxis (Bern 1994); 2011 Nov; 100(23):1413-24. PubMed ID: 22086380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
    Kruis W; Neshta V; Pesegova M; Alekseeva O; Andreev P; Datsenko O; Levchenko O; Abdulkhakov S; Lozynskyy Y; Mostovoy Y; Soloviev K; Dorofeyev AE; Vieth M; Stiess M; Greinwald R; Mohrbacher R; Siegmund B
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):98-106.e4. PubMed ID: 29702300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
    Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
    J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis.
    Piodi LP; Ulivieri FM; Cermesoni L; Cesana BM
    Scand J Gastroenterol; 2004 Feb; 39(2):154-7. PubMed ID: 15000277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].
    Rufle W; Frühmorgen P; Huber W; Kimmig JM
    Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
    Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H
    Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.